Getz Pharma is a leading branded generic pharmaceutical company that develops, produces, and markets safe, effective, and quality medicines in over 45 countries. Getz Pharma's products are manufactured at its state-of-the-art pharmaceutical facility that adheres to the highest quality standards and its GMP is approved by the World Health Organization (WHO), PIC/S, and EAEU.
Pakistan
Getz Pharma, the largest branded generic pharmaceutical company in Pakistan, commenced its operations in 1995. Today, it stands as the largest investor, exporter, employer, and taxpayer in the pharmaceutical industry of Pakistan.
Getz Pharma's products are manufactured at its state-of-the-art pharmaceutical facility located in Karachi. The facility adheres to the highest standards of quality and its GMP is approved by the World Health Organization (WHO), PIC/S, and EAEU.
The company's diverse therapeutic portfolio includes:
- Cardiometabolic
- Gastroenterology
- Hepatology
- Pulmonology
- Urology
- Gynaecology
- Oncology
- Pediatrics
- Orthopaedics & Rheumatology
- Infectious Diseases
- Neuropsychiatry
- General Medicine
- Nephrology
Hong Kong
Getz Pharma started distributing its products in Hong Kong in 2008. In a market inundated with generic drugs, Getz Pharma products have made their presence felt in the market, and the company envisions expanding its presence by adding new therapeutic segments.
Getz Pharma offers products under the following therapeutic segments:
- Anti – Coagulation
- Anti – Depressant
- Anti – Histaminic
- Anti – Hypertensive
- Anti – Infective
- Anti – Lipidemic
Brands such as Fexet (Fexofenadine HCl) and Advant (Candesartan) are leading the market in their particular therapeutic segments. Pharmacies recommend Getz Pharma products, which is a source of immense pride for our team.
Moldova
Getz Pharma kicked off its operations in Moldova in 2019 with the following therapeutic segments:
- Anti-Asthmatic
- Antibiotic
- Anti-Viral
Georgia
In 2019, Getz Pharma initiated its presence in Georgia, and since then, the company has not only achieved operational excellence but has also launched impactful engagement initiatives, introducing cutting-edge healthcare solutions to the nation. Supported by a committed team of experts, Getz Pharma ensures seamless operations and the widespread delivery of its safe, effective medicines to patients throughout the country.
Over time, the company has made its footprints in the diversified therapeutic areas, which are:
- Anti-Hypertensives
- Anti-Ulcerant
- Anti-Anginal
- Antibiotic
- Anti-Asthmatics
- Anti-Lipidemic
- Urogynecologic
- Urology/Urinary Flow Enhancer
Dominican Republic
Getz Pharma has been supplying antibiotic and anti-diabetic medication in the Dominican Republic since 2020.
Iraq
In 2020, Getz Pharma established its footprints in Iraq where it operates in diversified therapeutic segments.
Our portfolio comprises the following therapeutic segments:
- Anti-Asthma
- Anti-Diabetic
- Anti-Heart Failure
- Anti-Hypertensive
- Anti-Muscarinic
- Anti-Asthmatics
- Antibiotic
- Anti-Coagulant
- Anti-Diabetic
- Anti-Epileptic
- Anti-Gout
- Anti-Histaminic & Anti-Allergic
- Anti-Hyperlipidemic
- Anti-Hypertensive
- Anti-Lipidemic
- Anti-Rheumatic
- Anti-Spasmodic
- Anti-Ulcerant
- Anti-Viral
Qatar
Getz Pharma is proud to hold a market share in the Gulf region as well, where it has been supplying a variety of medicines to Qatar since 2021.
In Qatar, Getz Pharma’s operations maneuver in the following therapeutic areas:
- Anti-Asthmatic
- Antibiotic
- Anti-Diabetic
- Anti-Epileptic
- Anti-Hypertensive
- Anti-Rheumatic
- Anti-Ulcerant
- Urinary Anti-Spasmodic
Yemen
Operational since 2009, Getz Pharma’s vision in Yemen is to serve the market with a continuously growing portfolio of innovative products. The company’s current portfolio in Yemen carries more than ten products, within the following therapeutic segments:
- Anti-Diabetic
- Anti-Infective
- Anti-Rheumatic
- Anti-Ulcerants
- Anti-Viral
A highly dedicated and skilled team, extensive knowledge of the market and a wide distribution network helps us deliver quality products in a timely manner.
Azerbaijan
Getz Pharma Azerbaijan commenced its operations in 2021. We have a dedicated team of individuals working for the country who are committed to providing our innovative high-quality medicines to the patients and improving lives. Our presence in Azerbaijan is driven by the ambition to not only excel in therapeutic fields but also to positively transform the industry as a whole.
Democratic Republic of the Congo
Established in 2019, Getz Pharma has made a significant mark in DRC through its wide range of products catering to diverse therapeutic areas. The company not only holds a dominant position in multiple therapeutic segments but is also actively commencing involvement initiatives with healthcare professionals including doctors and pharmacists within the healthcare ecosystem.
Getz Pharma operates in the following segments in DRC:
- Anti-Convulsant
- Anti-Diabetic
- Anti-Lipidemic
- Antibiotic
- Anti-Asthmatics
- Urogynecologic
- Anti-Rheumatic
Guyana
Getz Pharma holds a competitive market share in the categories of antibiotics and anti-convulsants in Guyana. The company started operations in the year 2021, in the following therapeutic areas:
- Anti-Convulsant
- Antibiotic
Ivory Coast
Getz Pharma kick-started its sales operations in the Ivory Coast in the year 2021.
The company has been contributing to the region’s pharmaceutical industry in the following therapeutic segments:
- Anti-Asthmatic
- Anti-Gout
- Anti-Diabetic
- Anti-Viral
Nigeria
Incorporated in October 2009, Getz Pharma Nigeria Pvt. Limited commenced operations in 2012 in Nigeria. The company operates with strong, motivated sales and marketing teams, and a strong distribution network across Africa, offering a wide array of brands within the following therapeutic segments:
- Anti-Asthmatic
- Anti-Histaminic
- Anti-Infective
- Anti-Lipidemic
- Anti-Malarial
- Anti-Obesity
- Anti-Osteoporotic
- Anti-Rheumatic
- Anti-Ulcerants
- Cardio-Metabolic
Uzbekistan
Getz Pharma began its business operations in Uzbekistan in 2021 with a vision to be ranked among the top generic pharmaceutical companies in the country. By harnessing its expertise, resources, and forward-thinking approach, Getz Pharma Uzbekistan strives to not only attain its vision but to exceed expectations in the sphere of pharmaceuticals within the country.
Getz Pharma Uzbekistan is working on the following therapeutic segments:
- Antibiotic
- Anti-Asthmatic
- Anti-Lipidemic
- Anti-Diabetic
- Urogynecologic
- Urinary Flow Enhancer/ Urology
Kazakhstan
Getz Pharma set up its Representative Office in Kazakhstan in 2009. The company’s primary vision is to improve the health of the citizens of the Republic of Kazakhstan by providing high quality pharmaceutical products at affordable prices.
In a region dominated by Western European generic companies, Getz Pharma envisions sustainable development based on corporate values in major therapeutic areas through the creation of an industry-leading portfolio of products and preparations.
Since inception, Getz Pharma’s operations in Kazakhstan have grown at a rapid pace: the company was awarded the ‘Crystal Star’ Award, and declared ‘Best New Pharmaceutical Company for 2010 in Kazakhstan’. This award was presented to Getz Pharma for being the most dynamically developing young company in the country.
In Kazakhstan, Getz Pharma currently offers a wide range of brands under the following therapeutic segments:
- Anti-Allergic
- Anti-Infective
- Anti-Rheumatic
- Anti-Ulcerants
- Cardio-Metabolic
- Uro-Genital
The Getz Pharma Kazakhstan team, comprising of qualified doctors and pharmacists, is highly committed, and works towards major targets in cohesion.
Tajikistan
Getz Pharma started marketing its products in Tajikistan in 2008, marking the company’s entry into the Commonwealth of Independent States (CIS) region.
In Tajikistan, Getz Pharma has identified the following key therapeutic segments:
- Anti-Allergic
- Anti-Infective
- Anti-Rheumatic
- Anti-Ulcerants
- Cardio-Metabolic
The company is dedicated to achieving leadership in these segments by fulfilling the unmet needs of the medical community and patients in Tajikistan.
Afghanistan
With a vision to maintain leadership position by continuously expanding product portfolio in the country, Getz Pharma commenced marketing and sales operations in Afghanistan in 2005. The company operates in Afghanistan with enthusiastic sales teams dedicated to ensure timely access to medicines. Getz Pharma achieved rapid growth in this country and maintains its leadership position in the market, with a wide range of products in the following therapeutic segments:
- Anti-Asthmatic
- Anti-Convulsant
- Anti-Histaminic
- Anti-Infective
- Anti-Lipidemic
- Anti-Malarial
- Anti-Obesity
- Anti-Osteoporotic
- Anti-Rheumatic
- Anti-Ulcerants
- Cardio-Metabolic
- Laxatives
- Neurophysiology
- Uro-Genital
Sri Lanka
Since commencement of its marketing and sales operations in Sri Lanka in 2002, Getz Pharma has gained momentum outpacing the industry growth rate, to become one of the top ten pharmaceutical companies in the country.
With a large number of brands available in the market, Getz Pharma Sri Lanka’s portfolio spans the following therapeutic segments:
- Anti-Convulsant
- Anti-Histaminic
- Anti-Infective
- Anti-Lipidemic
- Anti-Obesity
- Anti-Osteoporotic
- Anti-Rheumatic
- Anti-Ulcerants
- Cardio-metabolic
- Laxatives
- Neurophysiology
- Uro-Genital
The company is dedicated to achieving leadership in these segments by fulfilling the unmet needs of the medical community and patients in Tajikistan.
Uganda
Getz Pharma started its operations in Uganda in 2022 with the following therapeutic segments:
- Anti-Asthmatic
- Antibiotic
- Anti-Diabetic
- Anti-Histaminic & Anti-Allergic
- Anti-Hyperlipidemic
- Anti-Hypertensive
- Anti-Lipidemic
- Anti-Malarial
- Anti-Osteoporotic
- Anti-Rheumatic
- Anti-Ulcerant
Tanzania
Getz Pharma began exporting to Tanzania in 2018. The company has been providing medication to the aforementioned country in the following therapeutic areas:
- Anti-Convulsant
- Anti-Diabetic
- Urogynecologic
- Antibiotic
- Anti-Asthmatics
Libya
Getz Pharma expanded its operations to Libya in 2022 with a vision to offer the market a diverse range of high-quality pharmaceutical products. Our team of dedicated professionals possesses extensive market knowledge, and our vast distribution network enables us to deliver products to patients on time.
Our therapeutic segments include:
- Analgesic
- Anti-Asthmatic
- Antibiotic
- Anti-Diabetic
- Anti-Epileptic
- Anti-Histaminic & Anti-Allergic
- Anti-Hyperlipidemic
- Anti-Hypertensive
- Anti-Infertility
- Anti-Obesity
- Anti-Rheumatic
- Anti-Spasmodic
- Anti-Ulcerant
- Hematinic
- Other Urologicals
- Urinary Anti-Spasmodic
Kenya
Getz Pharma began marketing and sales operations in Kenya in 2007. The company has achieved double-digit growth year after year, and according to Information Medical Statistics (IMS), is amongst the top ten in the market. It is proud to be a responsible and dependable partner of the medical community in Kenya by supporting scientific causes and functions and participating in various continued medical education programs.
With a wide range of leading brands, Getz Pharma’s therapeutic segments in Kenya include the following:
- Anti-Allergic
- Anti-Asthmatics
- Antibiotic
- Anti-Coagulants
- Anti-Convulsant
- Anti-Diabetic
- Anti-Gout
- Anti-Hypertensive
- Anti-Lipidemic
- Anti-Rheumatic
- Anti-Ulcerant
- Urogenital/Antispasmodics
The Getz Pharma Kenyan team comprises of motivated individuals who share strong interpersonal relations and are passionate about setting and achieving goals.
Mauritius
Getz Pharma commenced distribution of its products in Mauritius in 2009 and with dedication, has been maintaining a strong presence in the country with recognized brands like Rovista (Rosuvastatin), Advant (Candesartan), Advantec (Candesartan + Hydrochlorothiazide), Trevia (Sitagliptin), and Treviamet (Sitagliptin+Metformin HCI), among other brands it markets under the following therapeutic segments:
- Anti – Asthmatic
- Anti – Convulsant
- Anti – Diabetics
- Anti – Histaminic
- Anti – Hypertensive
- Anti – Infectives
- Anti – Lipidemic
- Anti – Ulcerant
- Dietary Fat Absorption Inhibitor
Sudan
Getz Pharma started marketing products in Sudan in 2008, With a strong marketing strategy, well-educated and highly trained team and patient centric approach, Getz Pharma has achieved rapid growth in Sudan.
In Sudan, Getz Pharma products span the following therapeutic segments:
- Anti – Asthmatic
- Anti – Convulsant
- Anti – Diabetic
- Anti – Lipidemic
- Anti – Rheumatic
Getz Pharma pioneered Pregabalin (Gabica) and Rosuvastatin (Rovista) in Sudan, and is a market leader in these segments. Similarly, Glimepiride (Getryl), Montelukast (Montiget) and Hydroxychloroquine (HCQ) are also market leaders in their respective fields.
Thailand
Getz Pharma takes pride in exporting anti-asthmatic products in Thailand since the year 2021.
Cambodia
Getz Pharma commenced marketing and sales operations in Cambodia in 2007.
Getz Pharma is currently one of the fastest growing pharmaceutical companies in Cambodia and among the top three pharmaceutical companies in the country. It is operating through a highly engaged, energetic and motivated team, offering a wide range of brands within the following therapeutic segments:
- Analgesic
- Anti-Allergic
- Anti-Asthmatic
- Antibiotics
- Anti-Coagulant
- Anti-Convulsant
- Anti-Depressant
- Anti-Diabetic
- Anti-Diabetic (insulin analog)
- Anti-Gout
- Anti-Histaminic
- Anti-Hypertensive
- Anti-Rheumatic
- Anti-Lipidemic
- Anti-Osteoporotic
- Anti-Retroviral
- Anti-Spasmodic
- Anti-Ulcerant
- Anti-Viral
- Immunomodulator
- Urogenital/Antispasmodics
- Vitamin D Analogue
Laos
Getz Pharma began operations in Laos in 2007. With a range of quality and affordable products, sound understanding of local trends and a skilled and highly motivated team, Getz Pharma’s growth rate greatly outnumbers the industry growth rate.
In Laos, Getz Pharma offers a large number of brands under the following therapeutic segments:
- Anti-Allergic
- Anti-Asthmatic
- Antibiotic
- Anti-Convulsant
- Anti-Diabetic
- Anti-Histaminic
- Anti-Lipidemic
- Anti-Osteoporotic
- Anti-Ulcerant
Malaysia
Getz Pharma has a strong presence in the multicultural Malaysian market. With a robust distribution network and a portfolio of quality generic medicines at affordable prices, the company is tuned to the changing needs of patients.
As part of our mission to develop, produce and market safe, effective and quality medicines and health care products that improve the health of men, women and children, products under the following therapeutic segments are marketed in Malaysia:
- Anti-Asthmatic
- Anti-Diabetic
The highly motivated and dedicated teams in Malaysia aim to deliver the highest standards of services.
Myanmar
Getz Pharma commenced operations in Myanmar in 2008. Since then, it has grown to become one of the top pharmaceutical companies by far, outpacing the industry growth rate.
The Getz Pharma team in Myanmar markets a growing number of brands, under the following therapeutic segments:
- Anti – Asthmatic
- Anti – Convulsant
- Anti – Depressant
- Anti – Diabetic
- Anti – Histaminic
- Anti – Hypertensive
- Anti – Infective
- Anti – Lipidemic
- Anti – Rheumatic
- Anti – Spasmodic / Anti – Cholinergic
- Anti – Ulcerant
- Anti – Viral
- Dietary Fat Absorption Inhibitor
- Immunomodulatory
Philippines
Getz Pharma (Philippines.), Inc. started operations in 2005 and has established significant presence nationwide in the market in the form of highly qualified, agile and passionate marketing, sales and support teams.
Five years into operations, Getz Pharma Philippines became one of the top twenty pharmaceutical companies in the country and is accredited by Professional Regulation Commission (PRC) as a Certified Training Provider.
Philippines is a high growth branded generics market where Getz Pharma markets its products under the following therapeutic segments:
- Cardiology
- Diabetology
- Infectious diseases
- Gastroenterology and Hepatology
- Lipidology
- Orthopedics and Rheumatology
- Pulmonology
- Urology
Vietnam
The Getz Pharma Representative Office in Vietnam has been operational since 1999. The company is rated as one of the fastest growing pharmaceutical companies and aims to qualify amongst the top branded generic pharmaceutical companies in this market. The variety of products offered are under the following therapeutic segments:
- Anti-Asthmatics
- Antihistaminic and Antiallergic
- Anti-Obesity
- Cardiology & Lipidology
- Diabetology
- Hepatology
- Infectious diseases
- Gastroenterology
- Orthopedics & Rheumatology
